Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species
- PMID: 240655
Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species
Abstract
Comparative studies of in vitro drug metabolism by hepatic and extrahepatic tissues have been complicated by the use of a single experimental tissue, few animal species, and variable experimental conditions. In an attempt to minimize these complications, liver, lung and kidney from rat, mouse, rabbit, hamster, and guinea pig were assayed for standard microsomal and soluble fraction enzymes involved in drug biotransformation. For all species, liver was the most active organ. Kidney and lung activities were usually 15%-40% of those found in liver, with kidney slightly more active than lung. No single species demonstrated total superiority in its drug-metabolizing ability, although hamster showed a large number of instances of greatest activity. The rat was a surprisingly poor representative of drug-metabolizing ability; it was superior to the other four species in less than 25% of the instances studied. All species appeared to N-demethylate aminopyrine equally except for high pulmonary and nearly absent renal activities in rabbit and high hepatic activity in hamster. Rat had the lowest level of cytochrome P-450 and low activity of NADPH-cytochrome c reductase. UDP-glucuronyltransferase activity toward the acceptors p-nitrophenol and o-aminophenol was higher in hamster and rabbit than other species. Guinea pig appeared to have the most active soluble fraction enzymes. Mouse lung and kidney had glutathione S-aryltransferase activities 10-fold greater than any other species and comparable to liver activity from rabbit and hamster.
Similar articles
-
Biochemical properties of some microsomal xenobiotic-metabolizing enzymes in rabbit small intestine.Drug Metab Dispos. 1976 May-Jun;4(3):208-14. Drug Metab Dispos. 1976. PMID: 6224
-
Drug metabolism in adult rat hepatocytes in primary monolayer culture.Gastroenterology. 1977 Jun;72(6):1232-9. Gastroenterology. 1977. PMID: 404208
-
Preservation of various microsomal drug metabolizing components in tissue preparations from the livers, lungs, and small intestines of rodents.Drug Metab Dispos. 1976 Sep-Oct;4(5):451-9. Drug Metab Dispos. 1976. PMID: 10144
-
Laboratory methods for ten hepatic toxification/detoxification parameters.Methods Find Exp Clin Pharmacol. 1983 Sep;5(7):439-48. Methods Find Exp Clin Pharmacol. 1983. PMID: 6422171 Review.
-
Multiplicity of liver drug metabolizing enzymes.Drug Metab Rev. 1979;10(2):187-208. doi: 10.3109/03602537908997468. Drug Metab Rev. 1979. PMID: 121803 Review. No abstract available.
Cited by
-
Liver proteome analysis of grass carp (Ctenopharyngodon idellus) following treatment with enrofloxacin.Fish Physiol Biochem. 2019 Dec;45(6):1941-1952. doi: 10.1007/s10695-019-00690-x. Epub 2019 Aug 10. Fish Physiol Biochem. 2019. PMID: 31399919
-
Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs.Br J Clin Pharmacol. 2016 May;81(5):849-56. doi: 10.1111/bcp.12876. Epub 2016 Mar 2. Br J Clin Pharmacol. 2016. PMID: 26714256 Free PMC article. Review.
-
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.Nat Commun. 2022 Aug 30;13(1):5108. doi: 10.1038/s41467-022-32565-w. Nat Commun. 2022. PMID: 36042198 Free PMC article.
-
Interaction between udenafil and tamsulosin in rats: non-competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2.Br J Pharmacol. 2009 Mar;156(6):1009-18. doi: 10.1111/j.1476-5381.2008.00099.x. Epub 2009 Feb 26. Br J Pharmacol. 2009. PMID: 19254278 Free PMC article.
-
Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.Transl Res. 2011 Jul;158(1):54-70. doi: 10.1016/j.trsl.2011.02.003. Epub 2011 Mar 9. Transl Res. 2011. PMID: 21708356 Free PMC article.